Publication | Closed Access

A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis

Pilot TrialCentral PainHealth SciencesNeurological DisorderPain MedicineMedicineNeuropathic PainPain ManagementNeurologyMultiple SclerosisNeuroimmunologyPain Research